The JOURNAL OF BIOLOGICAL PHYSICS, published by Springer, is a premier interdisciplinary journal that focuses on the intersection of biological sciences and physics. With an ISSN of 0092-0606 and an E-ISSN of 1573-0689, this journal serves as a significant platform for researchers and professionals to publish innovative studies, covering fields such as atomic and molecular physics, biophysics, cell biology, and molecular biology. The journal has been a key player since its inception in 1973, showcasing rigorous scientific inquiry and advancing knowledge within these domains, reflected in its categorization in the Q3 and Q4 quartiles of various relevant fields as of 2023. While it currently operates without an Open Access model, the journal continues to provide pivotal contributions to its audience, supporting academic and practical advancements in biological physics while engaging a broad scope of scholarly discourse.

Quarterly Reviews of Biophysics, published by Cambridge University Press, is a premier academic journal dedicated to the field of biophysics. With an impressive impact factor reflecting its esteemed reputation, this journal occupies a distinguished position as evidenced by its Q1 category ranking in Biophysics and its ranking of #7 out of 152 in the Scopus database, placing it in the top 5% of its field. The journal has been a significant contributor to the scientific community since its inception in 1968, offering insightful reviews and analysis that bridge the disciplines of biochemistry, genetics, and molecular biology. Quarterly Reviews of Biophysics provides an invaluable platform for researchers, professionals, and students alike to access high-quality, peer-reviewed content that enhances understanding of molecular interactions and systems biology. While Open Access is not currently offered, the journal remains committed to disseminating critical knowledge to advance research and innovation in biophysics.

Biochemistry Moscow Supplement Series A-Membrane and Cell Biology, published by PLEIADES PUBLISHING INC in the United States, is a pivotal journal in the fields of biochemistry, biophysics, and cell biology. Established in 2008, this journal has become a significant platform for disseminating novel research findings and reviews, fostering advanced studies in membrane dynamics and cellular processes. Although currently ranked in the Q4 quartile across its categories, the journal provides researchers and professionals with open access to a wealth of knowledge, helping to bridge gaps in understanding complex biochemical mechanisms. The journal’s commitment to quality and relevance is evident as it continues to contribute to the academic community through its coverage of innovative and emerging topics in cell and membrane biology. Researchers, practitioners, and students alike will find this resource invaluable for keeping abreast of the latest developments in the ever-evolving landscape of biochemistry and cellular research.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, published by Elsevier, serves as a pivotal journal in the fields of biochemistry and biophysics, with a long-standing history dating back to 1956. This esteemed publication, bearing the ISSN 0304-4165 and E-ISSN 1872-8006, continuously contributes to advancing our understanding of complex biological processes through rigorous research articles and reviews. It notably holds a distinguished position with a Q2 classification in Biochemistry and a Q1 ranking in Biophysics for 2023, reflecting its high relevance and impact within these scientific domains. The journal is also recognized within the Scopus metrics, taking a rank of #40 out of 152 in Biophysics and #173 out of 438 in Biochemistry, thus placing it in the 74th and 60th percentiles respectively. Academics and professionals in the life sciences will find this journal an essential resource for current research, cutting-edge techniques, and comprehensive reviews aimed at enhancing the understanding of biological functions. While BIOCHIMICA ET BIOPHYSICA ACTA is not an open-access journal, it remains a cornerstone publication for those seeking to stay at the forefront of biochemical and biophysical research.

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

TRAFFIC is a distinguished academic journal published by Wiley, serving as a vital resource in the fields of Biochemistry, Cell Biology, Genetics, Molecular Biology, and Structural Biology. With an impressive growth trajectory since its inception in 2000, the journal has consistently maintained a Q1 category ranking in the latest 2023 evaluations, placing it amongst the top-tier publications in its fields. TRAFFIC is based in Denmark and has become a cornerstone for researchers and professionals seeking to explore the intricate dynamics of cellular transport and its implications across biological processes. Despite not being an open-access journal, TRAFFIC offers comprehensive access options, ensuring vital contributions to the scientific community are readily available. With a proven track record and substantial impact, as evidenced by its Scopus rankings—such as rank #11 in Structural Biology—TRAFFIC continues to be an essential platform for disseminating influential research and fostering academic discourse.

AIMS Biophysics, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing the fields of biophysics, biochemistry, molecular biology, and structural biology. Launched in 2014, this journal provides a platform for researchers and professionals to disseminate high-quality research findings that contribute to the understanding of complex biological systems at the molecular level. With an ISSN of 2377-9098, AIMS Biophysics is indexed in Scopus, where it ranks in the fourth quartile across several categories, reflecting its commitment to addressing important issues within the scientific community. The journal aims to foster interdisciplinary collaboration and innovation through the publication of original research, reviews, and methodologies that advance the field. The open-access model ensures that cutting-edge research is freely available, promoting global access to scientific knowledge and enhancing visibility for authors. Nestled in the vibrant scientific landscape of the United States, AIMS Biophysics is poised to impact the evolving discourse in biophysics and related areas as it continues through its convergence period from 2014 to 2024.

Integrative Biology, published by Oxford University Press, is a dynamic journal at the intersection of biochemistry, biophysics, and broad spectrum medicine. Since its inaugural issue in 2009, the journal has established itself as a significant platform for disseminating transformative research that explores the integration of biological disciplines. With a commendable Q2 ranking in Biophysics and a Q3 ranking in Biochemistry for 2023, it attracts high-quality submissions and maintains rigorous peer-review standards. The journal serves as an essential resource for researchers, professionals, and students seeking to advance their understanding of complex biological systems through innovative and interdisciplinary approaches. While currently not an open access publication, it offers various access options to cater to its diverse readership. With an ongoing commitment to fostering collaboration and knowledge exchange within the scientific community, Integrative Biology continues to play a pivotal role in shaping contemporary biological research.

European Biophysics Journal with Biophysics Letters is a leading academic journal published by Springer that focuses on innovative research in the field of biophysics. Founded in 1984, it has consistently provided a platform for the dissemination of high-quality scientific findings, bridging the gap between biophysics and its applications in medicine and related fields. With an ISSN of 0175-7571 and an E-ISSN of 1432-1017, this journal has established itself as a Q2-rated publication in both Biophysics and Miscellaneous Medicine, highlighting its influential role in advancing knowledge and fostering collaboration among researchers. The journal features original research articles, reviews, and technical notes that contribute significantly to our understanding of biological systems at a molecular level. Although it does not offer an open-access model, the journal remains committed to promoting scholarly communication and enhancing the visibility of biophysical research globally. By maintaining a Scopus Rank of #74/152 within the category of Biochemistry, Genetics and Molecular Biology, it positions itself as an essential resource for professionals, researchers, and students aiming to stay at the forefront of biophysical science.

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.